logo

Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast

  3 weeks ago   
post image
NEW YORK, Oct. 25, 2024 ( GLOBE NEWSWIRE ) -- Y-mAbs Therapeutics, Inc. ( the "Company" or "Y-mAbs" ) ( Nasdaq: YMAB ) , a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the ...
Ticker Sentiment Impact
YMAB
Neutral
13 %